Home

Welcome to MyIDSA

Welcome to MyIDSA, IDSA’s Member-Only Community! Connect with Colleagues, Share Resources, Start or Join a Lively Discussion. Join us…It’s Infectious!

JOIN THE DISCUSSION

Recent Discussions

  • Posted in: IDea Exchange

    I have also found the following to be helpful in determining salary allotments for ASP/IP in regards to your BATNA: gross annual ID patient care generated revenue / 2000 = hourly net worth to the system I believe this assumes roughly 4 wks vacation ...

  • Posted in: IDea Exchange

    ​I clarified the IDCases and PubMed issue with them for anyone interested - this was their response... Articles published in IDCR will not be indexed in PubMed. Also, since your paper is not funded by any recognized NIH funding body. I am sorry to ...

  • Posted in: IDea Exchange

    Thank you all for your help! ------------------------------ Anandit Mu DO ID Faculty UCSF Fresno Fresno CA ------------------------------

New Guidelines Update

IDSA Infectious Diarrhea Guidelines

 

Practice Guidelines

Member Spotlight

Sophia Koo, MD, SM, FIDSA has been selected as a semifinalist in the first round of the U.S. Department of Health and Human Services (HHS) Antimicrobial Resistance Diagnostic Challenge, a $20 million federal prize competition seeking innovative, rapid point-of-care laboratory diagnostic tests to combat the development and spread of drug resistant bacteria. Dr. Koo will receive $50,000 to develop her concept, “Breath volatile metabolites for the rapid identification of pneumonia etiology,” into a prototype. The proposal outlines a novel approach to community acquired pneumonia (CAP) diagnosis based on distinct differences in the breath volatile metabolite profiles of patients with bacterial vs. viral pneumonia.

Dr. Koo is with Harvard Medical and the Dana-Farber Cancer Institute and is a member of IDSA’s Diagnostics Committee.

News

  • Don't eat the raw dough from your Christmas cookies, FDA warns

    The U.S. Food and Drug Administration issued a new warning against consuming raw cookie dough as Christmas cookie season gets underway.
  • Stopping the Rise of Superbugs by Making Them Fight For Food

    The history of antibiotics is a history of running in place.

Help attract the best and brightest to the field of infectious diseases.

IDSA Foundation

Upcoming Events


  • Wednesday
    3
    October

    IDWeek 2018

    Wednesday, October 3 - Sunday, October 7, 2018
    Registration will open for members on March 6, and to everyone on April 3.
    San Francisco, CA, United States

IDSA has been important in my career in infectious disease. IDSA also plays a big role in advocacy and drawing attention to key issues. It's exciting to be a part of that and feel that I have an avenue for my voice to be heard.
Ingrid Bassett, MD, MPH, FIDSA
The idea that I could link epidemiology with my fundamental knowledge of how microorganisms work, along with diagnostic microbiology...this is an amazing way to put the pieces of the puzzles together about how infectious diseases work in human beings.
Lucy Tompkins, MD, PhD, FIDSA
I always like mystery stories growing up and you have to be very astute...You have to look at the symptoms, the geography, the home and social situation to solve the mystery of their problem.
Susan Bleasdale, MD
You can take a patient in front of you, and within a short amount of time with your clinical care, have an enormous impact.
John Lynch, MD, MPH
Understanding the pathogenesis of infectious diseases requires a knowledge of pathology, immunology, especially microbiology. The discipline allows practitioners to combine all of those, and there's never a dull moment.
Philip Polgreen, MD, MPH
I just became a member of IDSA this year, and I find it amazing how supportive IDSA has been to me so far.
Noah Kojima, MD